Small Molecule Therapies for Rheumatoid Arthritis: Global Markets to 2022

Published - Apr 2018| Code - PHM195A| Analyst - BCC Research Reference Staff

Report Highlights

The global small molecule therapies for rheumatoid arthritis market totaled $1.7 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 6.6% for the period of 2017-2022.

Report Includes

  • 95 data tables
  • Country specific data and analysis for China, India, Japan, Australia, United Kingdom, Germany, France, Italy, Spain, Russia, USA, and Brazil
  • Identification of segments with high growth potential and their future applications
  • Explanation of major drivers and regional dynamics of the market and current trends within the industry
  • Detailed profiles of major vendors in the market, including AbbVie Inc., Amgen Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche AG and Pfizer Inc.

Report Scope

This research report categorizes the small molecule therapies for rheumatoid arthritis market by product type. Product type include disease modifying anti-rheumatic drugs, non-steroidal anti-inflammatory drugs and corticosteroids.

Analyst Credentials

BCC Research analysts craft reference reports with a unique end noted referencing methodology, which allows users to cross reference and trace market numbers back to their source. These individuals are experts in secondary research and primary forecasting - compiling and layering existing data with their original research and analysis. The team has decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Note: Reports are discounted or included with certain Memberships. See Membership Options.
Title/Chapter Name Pages Price Member Price
Full Report: Small Molecule Therapies for Rheumatoid Arthritis: Global Markets to 2022 171 $5,500 Free
Chapter- 1: Introduction5Free DownloadFree
Chapter- 2: Summary and Highlights2$250Free
Chapter- 3: Small Molecule Therapies for Rheumatoid Arthritis Market Characteristics2$65Free
Chapter- 4: Small Molecule Therapies for Rheumatoid Arthritis Market Size and Growth5$163Free
Chapter- 5: Small Molecule Therapies for Rheumatoid Arthritis Market Trends and Strategies2$65Free
Chapter- 6: PESTLE Analysis6$195Free
Chapter- 7: Small Molecule Therapies for Rheumatoid Arthritis Market Segmentation4$130Free
Chapter- 8: Small Molecule Therapies for Rheumatoid Arthritis Market Regional and Country Analysis9$293Free
Chapter- 9: Global Small Molecule Therapies for Rheumatoid Arthritis Market Comparison with Macro Economic Factors3$98Free
Chapter- 10: Asia-Pacific Small Molecule Therapies for Rheumatoid Arthritis Market8$260Free
Chapter- 11: Asia-Pacific Small Molecule Therapies for Rheumatoid Arthritis Market: Country Analysis24$781Free
Chapter- 12: Western Europe Small Molecule Therapies for Rheumatoid Arthritis Market8$260Free
Chapter- 13: Western Europe Small Molecule Therapies for Rheumatoid Arthritis Market: Country Analysis25$814Free
Chapter- 14: Eastern Europe Small Molecule Therapies for Rheumatoid Arthritis Market8$260Free
Chapter- 15: Eastern Europe Small Molecule Therapies for Rheumatoid Arthritis Market: Country Analysis5$163Free
Chapter- 16: North America Small Molecule Therapies for Rheumatoid Arthritis Market8$260Free
Chapter- 17: North America Small Molecule Therapies for Rheumatoid Arthritis Market: Country Analysis5$163Free
Chapter- 18: South America Small Molecule Therapies for Rheumatoid Arthritis Market8$260Free
Chapter- 19: South America Small Molecule Therapies for Rheumatoid Arthritis Market: Country Analysis5$163Free
Chapter- 20: Middle East Small Molecule Therapies for Rheumatoid Arthritis Market7$228Free
Chapter- 21: Africa Small Molecule Therapies for Rheumatoid Arthritis Market6$195Free
Chapter- 22: Small Molecule Therapies for Rheumatoid Arthritis Market Customer Information2$65Free
Chapter- 23: Small Molecule Therapies for Rheumatoid Arthritis Market Competitive Landscape11$358Free
Chapter- 24: Key Mergers and Acquisitions in the Small Molecule Therapies for Rheumatoid Arthritis Market1$33Free
Chapter- 25: APPENDIX2$65Free
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
The Global Market for Pain Management Drugs and Devices

The global market for pain management will grow from nearly $36.1 billion in 2017 to $52.0 billion by 2022, with a compound annual growth rate (CAGR) of 7.6% for the period of 2017-2022.

Melissa Elder | Aug 2017

Global Markets for Generic Drugs

The global market for generic drugs should reach $533 billion by 2021 from $352 billion in 2016 at a compound annual growth rate (CAGR) of 8.7%, from 2016 to 2021.

Paul Evers | Feb 2017

Share This Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts assess growth opportunities, market sizing, technologies, applications, supply chains and companies with the singular goal of helping you make informed business decisions, free of noise and hype.

Contact
© 2019 BCC Research
Privacy Policy |Site Map|Terms & Conditions